Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown Lines
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
NT 201 is a botulinum toxin type A preparation free of complexing proteins, i.e. free of
proteins other than the active toxin. Injected into the muscle, NT 201 causes local weakening
to full paralysis depending on the administered dose. Botulinum toxin type A is widely used
for aesthetic treatment of facial lines. This study will determine the optimal dose of NT 201
in the treatment of glabellar frown lines.
Phase:
Phase 2
Details
Lead Sponsor:
Merz Pharmaceuticals GmbH
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA